ScholarIQanswers from OpenAlex

Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective

PaperCitations, authors & open-access status

Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective have?

ScholarIQcitation count

Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective has 397 citations in the OpenAlex counts ScholarIQ stores.

When was Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective published?

ScholarIQyear

Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective has 2016 year in the ScholarIQ index.

What is the open-access status of Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective?

ScholarIQoa status

Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective has green oa status in the ScholarIQ index.

What is the DOI of Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective?

ScholarIQdoi

The DOI for Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective is on the source record.

What is the PMID of Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective?

ScholarIQpmid

The PMID for Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective is on the source record.

What is the OpenAlex record for Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective?

ScholarIQopenalex

The OpenAlex for Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial